The medicube Age-R Ultra Tune 40.68 is the Beyoncé of beauty tools
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change.
Let's talk skincare gadgets. Because let's face it: we've all been seduced by that sleek ad, the influencer with glass skin or the promise that this one little device will reverse the effects of binge-watching Netflix under fluorescent lights while eating cheese puffs.
Enter the medicube Age-R Ultra Tune 40.68 — a name that sounds like a spaceship but is specially designed to make your face look like it drinks collagen for breakfast.
As someone who reports on and reviews the best beauty brands for a living, I'm here to tell you that medicube is certainly worth it. Now, its device is beating the same buzzy drum.
Amazon
This snazzy Korean-made device is marketed as a '2-in-1 high-frequency + microcurrent' tool. Translation: it uses tiny zaps and heat to wake up your collagen, tighten any sagging skin and lift those brows like a pop diva hitting a high note.
According to medicube, it's the closest you can get to a med spa treatment without leaving your house (and, that's always a plus).
If you're in the mood for a skincare investment, this device feels like unwrapping tech from the future. It's white, sleek and vaguely resembles something that might take your temperature — or steal your Wi-Fi.
As far as aesthetics go, it checks every box. Just don't expect it to fit neatly in your carry-on unless you travel with a dedicated 'skincare gadgets only' suitcase (no judgment if you do).
How it works
No goopy gel? Count me in. The medicube Age-R Ultra Tune 40.68 glides over your skin, gently warming as it goes, thanks to its 40.68 MHz frequency — which, according to science (and medicube's marketing team), is the sweet spot for stimulating collagen. There's also a microcurrent setting that tightens like your face just did Pilates. The experience is warm, slightly tingly and weirdly satisfying.
Most reviewers say it's like a cozy face sauna. The Ultra Tune comes with six interchangeable heads, each designed to contour around your face like a skincare GPS. There's one for cheeks, one for your jawline and one for around your eyes. It's basically the Swiss Army knife of facial tools.
Bonus: It makes you feel like a highly-trained beauty assassin on a mission to slay wrinkles.
It's easy to use, and you don't need a special gel. Simply use the Ultra Tune after your skincare products have fully absorbed. It will help boost your skin's radiance and elasticity when used consistently, which is the best part.
People are seeing real results, too. Reviewers have posted everything from 'my cheeks look lifted' to 'I finally have cheekbones and didn't have to contour.' And yes, we're talking after just a few uses. But others say it's more of a 'slow and steady wins the race' situation. TL;DR: this isn't a Disney princess transformation; consistency is key.
You can also maximize your results with the AGE-R App that features custom guide videos, a tracking calendar, visual progress tracking and personalized settings for your best experience. It's like a one-on-one consultation with your facialist.
Let's not tiptoe around it — this baby is $299. That's not exactly pocket change. But, compared to repeated spa visits, it's a steal. The real question is: will you actually use it three times a week, or will it become the world's fanciest dust collector? That's up to you to decide.
The bottom line
If you're skincare-obsessed, love a tech-forward approach, or just want to pretend you're giving yourself a facial while watching 'Bridgerton,' this device is for you. If your ideal skincare routine is 'splash water and hope for the best,' maybe skip it.
Honestly? The medicube Age-R Ultra Tune 40.68 brings the science and the sizzle. It's not perfect, it's not cheap but it works if you commit to using it consistently. It's only worth it if you consider this device like a skincare marriage of sorts, not a fling.
If you're tired of overpriced creams that promise the world and deliver very little, this device is a solid investment. It's bougie. It's bold. It's your new skincare BFF with benefits. Just remember: good skin takes time, tech and maybe a little caffeine.
This article was written by Victoria Giardina, New York Post Commerce Journalist & Content Strategist, who has spent countless hours researching, testing hundreds of products and comparing the latest makeup, skincare, hair and beauty items and trends to determine what's truly worth your hard-earned cash. She evaluates formulas, textures, ingredients and more, in addition to consulting medical and industry experts. Some of Victoria's latest conquests include testing the best vitamin C serums on the market, and a rinse-and-repeat review of the best shampoos of 2025. Victoria, who received a beauty industry essentials certification from the Fashion Institute of Technology, has been creating shopping guides for the New York Post since 2021 and previously held positions at Insider Reviews and CNN Underscored.
Looking for a headline-worthy haul? Keep shopping Post Wanted.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
'Love Is Blind' Alum Marshall Glaze Details Struggle with Suicidal Ideation
Warning: This story discusses suicide. If you or someone you know is in crisis, call 988 to reach the Suicide and Crisis Lifeline. You can also call the network, previously known as the National Suicide Prevention Lifeline, at 800-273-8255, text HOME to 741741 or visit for additional resources. A "Love Is Blind" alum is sharing a powerful message about mental health. Marshall Glaze, who appeared on Season 4 of the Netflix dating series, just opened up about a dark period in his life that occurred last year. While appearing on the latest episode of "Love Is Blind" alum AD Smith's "What's The Reality?" podcast, Glaze acknowledged that he experienced suicidal thoughts amid a mental health crisis. 'Last year was just very tough for me mentally, and I was going to take my own life,' he said. 'It just got to a point where, I had always been morbidly curious, but never thought about how to do it. And then, one day, I'm just down in the dumps, just crazy depressed. I feel like nothing is going right. That's what my internal monologue is telling me.' Glaze went on to explain that his internal "voices" and "darkness" kept getting "a little bit louder" and "a little bit darker." 'It just felt like the walls were just getting closer and closer and closer, and nothing — no favorite meal, no favorite movie, no favorite song — could lift me out of that. And I knew I had a problem when I was OK with, this particular time that I talked to my mom, I was OK with that being the last time I talked to her,' he recalled. Glaze, who noted that he typically talks to his mom several times a day, said he then knew something was wrong. 'I was going to do what I felt like I had to do, but I couldn't,' he said. Glaze said he decided to take a walk in his Seattle neighborhood to clear his head and said this simple act encouraged him to get help. 'I lived on a very busy street in downtown Seattle, and at any time of the day, there's buses, cars, bikes, people walking, and nobody was out there — no cars, no buses, no bikes, no people, nothing," he said. After walking around in the deserted area, Glaze returned home and had an important realization. "I (was like), 'I want to live,'" he recalled. Smith told Glaze she was happy he decided to go on a walk and get fresh perspective. In response he said, "Thank you. Me too. I'm glad I'm here." "I'm glad you're here. We're all glad you're here," she said. While opening up about his decision to go public with his mental health challenges, Glaze acknowledged that the experience helps him "heal." "I hope that someone out there can resonate with that and choose life," he said. "Someone will for sure," Smith said. This article was originally published on
Yahoo
11 hours ago
- Yahoo
Common menopause medication might prevent breast cancer while treating hot flashes
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly reduced" breast tissue cell growth, which is a major indicator of cancer progression. A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. Prostate Cancer Drug Now Available To More Patients With Aggressive Form Of Disease This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Read On The Fox News App Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. "The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo," Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. Experimental Women's Cancer Drug Boosts Survival Rates In Notable Study Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. "This would be expected, as the drug is FDA-approved to treat hot flashes." Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The findings are preliminary and have not yet been published in a medical journal. "What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer," said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced "high-risk lesions" — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. "These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options," the release stated. The researchers said they are "encouraged" by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. "Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure," Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. "While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk," she told Fox News Digital. Click Here To Sign Up For Our Health Newsletter Kabraji also noted that the study focused on reducing levels of one specific protein, "which does not always predict reduced recurrence of breast cancer." "This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer," she noted. "Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention." For more Health articles, visit Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. "Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms," she article source: Common menopause medication might prevent breast cancer while treating hot flashes
Newsweek
16 hours ago
- Newsweek
Kroger Food Recall Update: Full List of Products Impacted
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Kroger has announced recalls of multiple products in May, citing concerns including potential salmonella contamination to manufacturing defects. The products range from food to kitchen items and kids' jewelry, and the recalls affect Kroger locations and its subsidiary stores nationwide. Dinty Moore Beef Stew Cans of Dinty Moore Beef Stew, 20 oz, produced by Hormel Foods Corporation, have been recalled due to the possibility that the products may be contaminated with foreign matter. The recall impacts Kroger stores in Ohio, Indiana, Virginia, Michigan, Illinois, Missouri, North Carolina, West Virginia and Kentucky. It also affects subsidiary stores that stock the products, such as Ralphs, Fred Meyer, Food4Less, FoodsCo and Smith's. The recalls were issued on May 29 and May 30. Customers who have purchased the products are advised not to eat them and can return them for a full refund. They can be identified by their product code 37600-21583 and a best buy date of February 2028. File photo of a Kroger grocery store in Centerville, Ohio. File photo of a Kroger grocery store in Centerville, Ohio. jetcityimage/Getty Images Cucumbers, Vegetable Platters and Salad Trays Kroger stores have recalled several salad items following a cucumber recall from Bedner Growers due to possible salmonella contamination. The items are: Deli Fresh Veg Tray Medium Deli Spring Mix Salad Tray BRHD Hummus Veg Platter Small BRHD Hummus Veg Platter Medium Cucumbers The products were recalled on May 21 and affected stores in the Greater Memphis area of Tennessee, as well as Arkansas, Mississippi, and Western Kentucky. Kroger stated that any of these salad items purchased between May 8 and 21, as well as cucumbers purchased between May 14 and 21, should not be consumed. Customers who purchased any of the affected items can return them for a full refund. Kroger warns that if ingested, these items could cause severe illness. The Bedner Growers cucumbers have been linked to a salmonella outbreak across the country, with multiple people reporting illness related to the cucumbers. Ninja Foodi Cooker The Ninja Foodi 6.5 Quart Cooker was recalled from Kroger stores and its subsidiaries on May 6 due to a lid defect. The recall applies to a wide range of locations, including stores in Ohio, Kentucky, Indiana, Michigan, Illinois, Missouri, the Carolinas, Virginia, West Virginia, Tennessee, Texas, Louisiana, Alabama, and other states. Disney Jewelry-Making Kits Disney jewelry-making kits have been recalled due to the risk of possible skin, eye, and respiratory irritation from uncured resin. The recall applies to Disney Little Mermaid Gel2Gem Sparkling Crystal Jewelry kits, which are stocked in Kroger subsidiaries Fred Meyer and Smith's stores. The recall was issued on May 5.
